These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 507256)

  • 1. A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature.
    Halperin W; Weiss WI; Altman R; Diamond MA; Black KJ; Iaci AW; Black HC; Goldfield M
    Am J Public Health; 1979 Dec; 69(12):1247-51. PubMed ID: 507256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of responses to influenza A/New Jersey/76-A/Victoria/75 virus vaccine administered intradermally or subcutaneously to adults with chronic respiratory disease.
    Herbert FA; Larke RP; Markstad EL
    J Infect Dis; 1979 Aug; 140(2):234-8. PubMed ID: 479641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intradermal administration of bivalent and monovalent influenza vaccines.
    Brooks JH; Criep LH; Ruben FL
    Ann Allergy; 1977 Aug; 39(2):110-2. PubMed ID: 889154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults.
    Brown H; Kasel JA; Freeman DM; Moise LD; Grose NP; Couch RB
    J Infect Dis; 1977 Dec; 136 Suppl():S466-71. PubMed ID: 606768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
    Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
    Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study.
    Arakane R; Annaka R; Takahama A; Ishida K; Yoshiike M; Nakayama T; Takeshita F
    Vaccine; 2015 Nov; 33(48):6650-8. PubMed ID: 26519549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
    Tsang P; Gorse GJ; Strout CB; Sperling M; Greenberg DP; Ozol-Godfrey A; DiazGranados C; Landolfi V
    Vaccine; 2014 May; 32(21):2507-17. PubMed ID: 24120672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
    Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18-64 years of age.
    Gorse GJ; Falsey AR; Johnson CM; Morrison D; Fried DL; Ervin JE; Greenberg DP; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2013 Dec; 31(50):6034-40. PubMed ID: 24055306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ; Falsey AR; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2015 Feb; 33(9):1151-9. PubMed ID: 25613721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis.
    Quach HQ; Kennedy RB
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Levin Y; Kochba E; Shukarev G; Rusch S; Herrera-Taracena G; van Damme P
    Vaccine; 2016 Oct; 34(44):5262-5272. PubMed ID: 27667332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
    Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of influenza vaccine among HIV-infected adults: Conventional vaccine vs. intradermal vaccine.
    Seo YB; Lee J; Song JY; Choi HJ; Cheong HJ; Kim WJ
    Hum Vaccin Immunother; 2016; 12(2):478-84. PubMed ID: 26431466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines.
    Wise TG; Dolin R; Mazur MH; Top FH; Edelman R; Ennis FA
    J Infect Dis; 1977 Dec; 136 Suppl():S507-17. PubMed ID: 342623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles children.
    Boyer KM; Cherry JD; Welliver RC; Deseda-Tous J; Zahradnik JM; Dudley JP; Krause PJ; Bryson YJ; Spencer MJ
    J Infect Dis; 1977 Dec; 136 Suppl():S661-4. PubMed ID: 342631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine.
    Coleman BL; McGeer AJ; Halperin SA; Langley JM; Shamout Y; Taddio A; Shah V; McNeil SA
    Vaccine; 2012 Sep; 30(44):6287-93. PubMed ID: 22902784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial.
    Hung IF; Zhang AJ; To KK; Chan JF; Li C; Zhu HS; Li P; Li C; Chan TC; Cheng VC; Chan KH; Yuen KY
    Clin Infect Dis; 2014 Nov; 59(9):1246-55. PubMed ID: 25048848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.